Inhibitory effects of P2Y12 receptor antagonists on TRAP-induced platelet aggregation, procoagulant activity, microparticle formation and intracellular calcium responses in patients with acute coronary syndromes

By Behan Miles W. H.   Fox Susan C.   Heptinstall Stan   Storey Robert F.  

Platelets, Vol. 16, Iss. 2, 2005-03 ,pp. : 73-80

Informa Healthcare

Access to resources Recommend Favorite

Effects of P2Y₁ and P2Y₁₂ receptor antagonists on platelet aggregation induced by different agonists in human whole blood

By Storey Robert F.   Newby Linda J.   Heptinstall Stan  

Platelets, Vol. 12, Iss. 7, 2001-11 ,pp. : 443-447

Informa Healthcare

Access to resources Recommend Favorite

Effects on platelet function of an EP3 receptor antagonist used alone and in combination with a P2Y 12 antagonist both in-vitro and ex-vivo in human volunteers

By Fox S.C.  

Platelets, Vol. 24, Iss. 5, 2013-08 ,pp. : 392-400

Informa Healthcare

Access to resources Recommend Favorite

Inhibitory Mechanisms of Dantrolene on Platelet Aggregation - Specific inhibition of platelet adhesion to collagen and relationship with cAMP level

By Chou T.-C.   Li C.-Y.  

Thrombosis Research, Vol. 96, Iss. 4, 1999-11 ,pp. : 299-307

Elsevier

Access to resources Recommend Favorite

Glycoprotein IIb/IIIa and P2Y12 receptor antagonists yield additive inhibition of platelet aggregation, granule secretion, soluble CD40L release and procoagulant responses

By Judge Heather M.   Buckland Robert J.   Holgate Carol E.   Storey Robert F.  

Platelets, Vol. 16, Iss. 7, 2005-11 ,pp. : 398-407

Informa Healthcare

Access to resources Recommend Favorite